Key Summary: Madryn Asset Management (4.2%) opposes the SomaLogic-Standard BioTools merger, soliciting "AGAINST" votes.
SomaLogic (SLGC) Stockholders Voted to…
Key Summary: Madryn Asset Management (4.2%) opposes the SomaLogic-Standard BioTools merger, soliciting "AGAINST" votes.